Related by context. All words. (Click for frequent words.) 74 Proxinium TM 74 oral prodrug 74 CTAP# Capsules 73 IMA# 73 TRO# 73 HuMax EGFr 73 OncoVEX GM CSF 72 Panzem R 72 Genasense ® oblimersen 72 Bezielle 72 Alocrest 72 targeted radiotherapeutic 72 Archexin 72 metaglidasen 71 liposomal formulation 71 HQK 71 PNP inhibitor 71 AEG# 71 Xanafide 71 PROVENGE sipuleucel T 71 Angiocept 71 delivers fluocinolone acetonide FA 70 drug ISA# 70 Panzem R NCD 70 elotuzumab 70 ELACYT 70 OncoVEX 70 eniluracil 70 phase IIb clinical 70 MEK inhibitor RDEA# 70 CR# vcMMAE 70 Cannabinor 70 OvaRex ® MAb 70 XmAb# 70 Symadex 70 Traficet EN 70 Amplimexon 70 LymphoStat B belimumab 70 SinuNase TM 70 Personalized Immunotherapy 70 bucindolol hydrochloride 70 CINQUIL 69 riociguat 69 lintuzumab SGN 69 CBLC# 69 novel VDA molecule 69 SNT MC# 69 Aflibercept 69 Azedra 69 anticancer compound 69 INCB# [001] 69 elacytarabine 69 Factor VIIa 69 sodium Injection 69 BrachySil TM 69 Chemophase 69 CYT# potent vascular disrupting 69 2 methoxyestradiol 69 candidate Gencaro TM 69 RLY# 69 TOCOSOL Camptothecin 69 PSMA ADC 69 YONDELIS 69 Safinamide 69 PEGylated interferon 69 RhuDex ® 69 CRLX# 69 CRMD# 69 mertansine 69 Glufosfamide 69 CEQ# 69 virus HCV protease inhibitor 69 MGd 69 #ME# 69 Onconase 69 CCX# 69 Curaxin CBLC# 69 therapeutic monoclonal antibody 69 lomitapide 69 Nanobody 69 ATL# [001] 69 acetonide FA 69 polysaccharide polymer 69 VitiGam 68 Dapagliflozin 68 Annamycin 68 DermaVir Patch 68 vidofludimus 68 PEG SN# 68 OHR/AVR# 68 R#/MEM # 68 forodesine 68 SinuNase ™ 68 DPX Survivac 68 JAK1 68 Carfilzomib 68 Picoplatin 68 Panzem 68 ApoB SNALP 68 dextofisopam 68 investigational pharmacologically unique 68 otelixizumab 68 Locteron ® 68 ZOLINZA 68 MAGE A3 ASCI 68 TBC# 68 investigational monoclonal antibody 68 Ketotransdel 68 compound INCB# 68 kidney urologic 68 MAXY G# 68 Androxal TM 68 Tarmogen 68 teriflunomide 68 ZK EPO 68 phase IIa clinical 68 Phase IIb clinical trials 68 p# biomarker 68 pomalidomide 68 TPI ASM8 68 OvaRex R 68 Vascugel 68 Oral NKTR 68 Exherin TM 68 CIMZIA TM 68 PDE4 inhibitor 68 Telatinib 68 Troxatyl 68 candidate TNFerade biologic 68 orally administered inhibitor 68 PRT# 68 PRTX 68 EDEMA3 trial 68 drug GAP #B# 68 huC# DM4 68 AAG geldanamycin analog 68 MYDICAR ® 68 Virulizin ® 68 Celacade TM technology 68 Aganocide 68 myelofibrosis polycythemia vera 68 investigational humanized monoclonal antibody 67 Dasatinib 67 Interferon alpha 67 evaluating tivozanib 67 ruxolitinib 67 personalized immunotherapy 67 relapsed multiple myeloma 67 CCR9 antagonist 67 antibody MAb 67 obatoclax 67 mapatumumab 67 PSN# [002] 67 depsipeptide 67 CYC# 67 Phase #b/#a clinical 67 CIMZIA ™ 67 ProSavin 67 Ophena 67 Sym# 67 docetaxel Taxotere ® 67 GAMMAGARD 67 Apoptone 67 including eniluracil ADH 67 Dacogen injection 67 Tyrima 67 PANVAC VF 67 anti CD3 antibody 67 Vernakalant 67 ISF# 67 oral ridaforolimus 67 selective modulator 67 selective androgen receptor modulator 67 NV1FGF 67 ENMD # 67 efaproxiral 67 registrational trial 67 Allovectin 7 67 candidate deforolimus 67 bardoxolone methyl 67 SPRYCEL ® 67 pertuzumab 67 BRIM2 67 oral rivaroxaban 67 standard chemotherapy regimen 67 indibulin 67 axitinib 67 molecular imaging radiopharmaceutical 67 BrachySil 67 Insegia 67 PEGylated Fab fragment 67 Marqibo TM 67 ALN TTR 67 investigational immunotherapy 67 DXL# 67 Pimavanserin 67 REG1 67 Genasense R oblimersen 67 pan HDAC inhibitor 67 Ceflatonin 67 Guanilib 67 Chrysalin 67 Ocrelizumab 67 MKC# MKC# PP 67 Ophena TM 67 HuMax CD4 67 Zybrestat 67 pain palliation 67 gefitinib Iressa 67 entinostat 67 HuLuc# 67 Sphingomab TM 67 Hsp# Inhibitor 67 GGF2 67 HspE7 67 thalidomide Thalomid 67 ALN PCS 67 deforolimus 67 Aptivus ® 67 trastuzumab Herceptin R 67 BZL# 67 TLR9 agonist 67 metastatic CRC 67 refractory gout 67 SUCCEED trial 67 Phase #b/#a trial 67 Microplasmin 67 catheter occlusion 67 Golimumab 67 Alpharadin 66 assessing T DM1 66 Kamada AAT 66 Arikace 66 GEM OS2 66 Atiprimod 66 Phase Ib study 66 Vicinium TM 66 Talabostat 66 Vidofludimus 66 HDL Mimetic Peptide 66 Natalizumab 66 RhuDex R 66 Mipomersen 66 PDX pralatrexate 66 histone deacetylase HDAC inhibitor 66 Fx #A 66 custirsen 66 candidate Zenvia 66 Aplidin 66 reslizumab 66 Rezular 66 corticosteroid dexamethasone 66 thymalfasin 66 Azedra TM 66 HGS ETR1 66 Tarvacin TM 66 Myocet 66 pexiganan 66 VAPRISOL 66 dasatinib Sprycel ® 66 Neo Kidney Augment 66 oral picoplatin 66 Iluvien ® 66 atacicept 66 acyclovir Lauriad R 66 allosteric modulator 66 Pegloticase 66 trial evaluating PRX# 66 glufosfamide 66 Amrubicin 66 samalizumab 66 QuadraSphere 66 PHX# 66 Irinotecan 66 ganetespib 66 Aviptadil 66 cannabinor 66 ribavirin RBV 66 Hedgehog Pathway Inhibitor 66 FOLFOX6 66 pharmacokinetic PK study 66 metastatic castration resistant 66 HEPLISAV Phase 66 Metastatic Melanoma 66 tanespimycin 66 lumiliximab 66 talactoferrin 66 Anticalin R 66 IL# PE#QQR 66 receptor tyrosine kinase inhibitor 66 vapreotide acetate 66 cediranib 66 motexafin gadolinium Injection 66 TLK# 66 immunotherapeutic agent 66 INT# [002] 66 lenalidomide Revlimid R 66 IAP inhibitor 66 SUTENT ® 66 apricitabine ATC 66 Meets Primary Endpoint 66 Azixa 66 relapsed MM 66 MGN# 66 Tezampanel 66 oxaliplatin Eloxatin 66 Corgentin 66 recombinant subunit vaccine 66 mRCC 66 Neo Urinary Conduit 66 TACI Ig 66 velafermin 66 Telintra 66 systemically administered 66 5 Fluorouracil 66 vorinostat 66 PrevOnco ™ 66 alvespimycin 66 Dyloject TM 66 targeted antifolate 66 Polymer Microspheres 66 Zemiva TM 66 LHRH antagonists 66 NeuroVax TM 66 seliciclib CYC# 66 Xcytrin R 66 torezolid phosphate 66 Omacetaxine 66 DOS# 66 Fludara ® 66 BENLYSTA TM 66 DP b# 66 Tesetaxel 66 TG# [003] 66 A3 adenosine receptor 66 Cleviprex TM clevidipine 66 HDL Selective Delipidation 66 Phase Ib clinical trials 66 #D#C# 66 Fodosine 66 inhaled liposomal ciprofloxacin 66 LEUKINE 66 CCR5 antagonist 66 pralatrexate 66 metastatic colorectal 66 Aurexis 66 HGS ETR1 mapatumumab 66 vascular disrupting agent 66 Genasense ® 66 Varespladib 66 TH# [003] 66 essential thrombocythemia ET 66 rNAPc2 66 Quinamed 66 enzastaurin 66 angiogenesis inhibitor 66 TYSABRI natalizumab 66 DAVANAT 66 Boceprevir 66 tiapamil 66 Trofex 66 HuMax TAC 66 mTOR inhibitor 66 proteasome inhibitor 66 ACAPODENE 66 HER2 positive metastatic breast 66 JAK inhibitor 66 ATL/TV# 66 PROLARIS 66 small molecule Hedgehog 66 EFAPROXYN 66 TELINTRA 66 Q#IR 65 delafloxacin 65 EndoTAG TM -1 65 JAK2 inhibitor 65 candidate XP# 65 DCVax R 65 Melphalan 65 Cetrorelix 65 phase IIb trial 65 CD# antibody [001] 65 paclitaxel poliglumex 65 phase IIb study 65 Fibrin Pad 65 XmAb ™ 65 generation purine nucleoside 65 gemcitabine Gemzar ® 65 trastuzumab Herceptin 65 sorafenib Nexavar 65 OMP #R# 65 Pirfenidone 65 favorable pharmacokinetic profile 65 personalized cellular immunotherapy 65 NP2 Enkephalin 65 budesonide foam 65 anti CD3 monoclonal 65 OMNARIS HFA 65 advanced carcinoid 65 RSR# 65 prostate cancer CRPC 65 Sudhir Agrawal D.Phil 65 immunotherapeutic vaccine 65 fluoropyrimidine 65 ON #.Na 65 Lixivaptan 65 gastrointestinal stromal tumors GIST 65 EGS# 65 Factor Xa inhibitor 65 glucagon receptor 65 resminostat 65 PORxin TM 65 GED aPC 65 nalbuphine ER 65 PEGylated anti 65 trastuzumab DM1 T DM1 65 Romiplostim 65 candidate NGX 65 Telbivudine 65 rALLy clinical trial 65 dasatinib Sprycel 65 PRX# 65 EGFR TKI 65 Phase 2a trial 65 ADVEXIN 65 ara C 65 ALN TTR# 65 Pertuzumab 65 GALNS 65 HDAC Inhibitor 65 Octreolin 65 Sapacitabine 65 ALGRX 65 non porcine pancreatic 65 CaPre TM 65 BiTE antibody 65 torezolid 65 somatostatin analogue 65 Initiates Enrollment 65 Gleevec imatinib mesylate 65 Intravenous CP 65 TKM ApoB 65 ILUVIEN ® 65 SinuNase 65 TransVax TM 65 CB2 selective receptor agonist 65 radiation sensitizer 65 fibrotic disease 65 vinca alkaloid 65 castration resistant prostate cancer 65 ThermoDox R 65 NAVISTAR R 65 MKC# MT 65 MT#/MEDI-# 65 Solazed TM 65 romidepsin 65 beta 1a 65 alkylating agent 65 ixabepilone 65 BAY #-# 65 HGS# 65 Altastaph 65 humanised monoclonal antibody 65 CA4P 65 cilengitide 65 RezularTM 65 Cloretazine ® 65 MNTX 65 G#DT 65 multi kinase inhibitor 65 PS# [001] 65 palifermin 65 EndoTAG 65 sodium thiosulfate STS 65 zalutumumab 65 sapacitabine CYC# 65 VEGFR2 inhibitor 65 tubulin inhibitor 65 sorafenib tablets 65 Randomized Phase 65 INCB# [003] 65 sipuleucel T 65 prophylactic vaccine 65 PI3K/Akt pathway inhibitor 65 THR beta agonist 65 MyVax R 65 PXD# 65 CoFactor 65 pipeline GlycoPEG GCSF 65 docetaxel Taxotere R 65 investigational HCV polymerase 65 Zenvia ™ 65 Plicera 65 Voreloxin 65 ulimorelin 65 evaluating picoplatin 65 chemotherapy induced neutropenia 65 investigational therapies 65 Perflubutane Polymer Microspheres 65 GVAX ® 65 gemcitabine Gemzar 65 Ferumoxytol 65 ONCONASE R 65 IgG1 antibody 65 vosaroxin 65 EOquin TM 65 DDP# 65 demonstrated antitumor activity 65 Allovectin 7 R 65 HSP# inhibitor 65 Fibrillex TM 65 ZYBRESTAT 65 thetreatment 65 intranasal formulation 65 anticancer agent 65 Degarelix 65 MyVax ® 65 IMiDs R 65 metastatic hormone refractory 65 Cethrin R 65 HCV protease inhibitor 65 oncolytic vaccine 65 Inhaled nitric oxide 65 EndoTAGTM 1 65 anti EGFR antibody 65 milatuzumab 65 preclinically 65 Thiarabine 65 LymphoStat B TM 65 NVA# 65 Vidaza azacitidine 65 colorectal cancer liver metastases 65 regorafenib 65 castrate resistant prostate cancer 65 systemic anaplastic large 65 orally bioavailable 65 Phase #/#a 65 Phase 2b Clinical Trial 65 Triolex 65 octreotide implant 65 Nanobody ® 65 monoclonal antibody MAb 65 TRV# [001] 65 Veronate 65 adecatumumab 65 BiovaxID TM 65 Epratuzumab 65 Evoltra ® 65 oral antiviral 65 CD# CEA 65 Campath alemtuzumab 65 Maribavir 65 Amigal 65 dimebon latrepirdine 65 TroVax ® 65 Tasimelteon 65 Muraglitazar 65 RAPAFLO 65 epigenetic therapies 65 topically applied SEPA 65 leading oral taxane 65 IIa trial 65 Selective Electrochemical Tumor Ablation 65 forodesine hydrochloride 65 carbohydrate polymer 65 Velcade bortezomib 65 orBec 65 relapsed MCL 65 Naproxcinod 65 Ostabolin C 65 Hematide TM 65 VNP#M 65 SERMs 65 Debio 65 PROCHYMAL 64 Pharmacokinetics PK 64 HGS ETR2 64 Solazed 64 candidate CRLX# 64 LHRH antagonist 64 lintuzumab 64 kinase inhibition 64 Targeted Chemotherapy 64 kallikrein 64 Octreotide 64 evaluating T DM1 64 ALV# 64 IMC A# 64 Peginterferon alfa 2b 64 MEK inhibitors 64 bevacizumab Avastin ® 64 Exelixis compounds 64 Cloretazine 64 refractory chronic lymphocytic 64 talabostat 64 favorable tolerability 64 Fibrin MB 64 hA# 64 FOLFOX6 chemotherapy regimen 64 signal transduction inhibitor 64 metastatic sarcomas 64 GRN# 64 urocortin 2 64 picoplatin 64 OncoGel 64 ATL# [002] 64 solithromycin 64 hyperphenylalaninemia HPA due 64 oblimersen 64 IMP# 64 EGFR tyrosine kinase inhibitor 64 accumulate preferentially 64 DermaVir 64 Hsp# inhibitor 64 small molecule activators 64 LibiGel ® 64 cangrelor 64 Lisofylline 64 motesanib 64 non nucleoside inhibitor 64 HuMax CD# 64 Cloretazine R VNP#M 64 GFT# 64 TriRima 64 L BLP# 64 GW# [003] 64 Pazopanib 64 ponatinib 64 Imprime PGG 64 palliative radiotherapy 64 KNS # 64 GLYX 64 candidate EFAPROXYN TM 64 inhibit metastasis 64 Generx ™ 64 FOLOTYN ® 64 bortezomib Velcade 64 DexaSite 64 INCB# [002] 64 HBeAg positive patients 64 multiple myeloma MM 64 ocular formulation 64 Abiraterone acetate 64 rxRNA 64 Simulect 64 selective orally bioavailable 64 Gleevec resistant 64 Combination REOLYSIN R 64 UPLYSO 64 Squalamine 64 pharmacological chaperone 64 CCX# B 64 cancer immunotherapies 64 Elotuzumab 64 Bicifadine 64 oxybutynin ATD TM 64 Interferon beta 64 vemurafenib 64 active cellular immunotherapy 64 Antiviral Activity 64 RNAi therapeutic targeting 64 candidate epratuzumab 64 CIMZIA TM certolizumab pegol 64 telomerase therapeutic 64 xanthine oxidase inhibitor 64 APOPTONE 64 alpha folate receptor 64 ZFP TF 64 IMiDs 64 Phase IIb trials 64 Phase #/#a trial 64 rALLy 64 cintredekin besudotox 64 intravesical infusion therapy 64 NEUMUNE 64 Pafuramidine 64 Panitumumab 64 Belerofon 64 Temsirolimus 64 HCV NS5B polymerase 64 menadione 64 Pegylated Interferon 64 Bucindolol 64 Fidaxomicin 64 Doxil ® 64 epithelial tumors 64 Enkephalin 64 Vandetanib 64 Preclinical studies suggest 64 PSN# [001] 64 Mepact 64 Zysolin TM 64 Ketotransdel TM 64 E1 INT TM 64 drug eluting stent DES 64 Spiegelmer ® 64 alemtuzumab Campath 64 Alfacell proprietary ribonuclease 64 mitogen activated ERK kinase 64 recurrent glioma 64 Multimeric 64 OMAPRO 64 VitiGam TM 64 davunetide intranasal AL 64 hylan GF 64 Prostate AdenoCarcinoma Treatment 64 JenaValve 64 Zingo TM 64 immunomodulator 64 Zolinza 64 Acute Radiation Syndrome ARS 64 Cardio Vascu Grow 64 Luteinizing Hormone Releasing Hormone 64 mGluR5 negative 64 PROVENGE ® 64 cytotoxic therapy 64 CYT# 64 huN# DM1 64 Epidermal Growth Factor Receptor 64 novel synthetic peptide 64 CytoFabTM 64 cobiprostone 64 MEK inhibitor 64 malignant ascites 64 KRN# 64 Virulizin R 64 histamine dihydrochloride 64 pancreatic colon 64 isoform selective 64 SPL# Gel vaginal microbicide 64 Targretin 64 Seliciclib 64 Bafetinib 64 CXB# 64 Tarceva TM 64 non metastatic osteosarcoma 64 REMUNE R 64 metastatic malignant 64 XYOTAX TM 64 SCCHN 64 M# rationally 64 Proxinium 64 tremelimumab 64 goserelin 64 non alcoholic steatohepatitis 64 metastatic carcinoid 64 Torisel 64 GRNCM1 64 Combivir Kivexa 64 VEGF receptor inhibitor 64 CRD5 64 imatinib Gleevec ® 64 QNEXA ® 64 posaconazole 64 Diabetic Macular Edema DME 64 BEMA TM Fentanyl 64 nucleotide analog 64 NPC 1C 64 apremilast 64 lucinactant 64 ACTEMRA TM 64 interferon gamma 1b 64 methylnaltrexone 64 herpetic keratitis 64 TRIOLEX 64 XL# anticancer compounds 64 XmAb 64 BHT DNA 64 Survivin antagonist 64 liposomal doxorubicin 64 immune modulating 64 Kahalalide F 64 EndoTAG TM 64 ongoing Phase 1b 64 ISIS # 64 CD# monoclonal antibody 64 Combo Stent 64 imatinib therapy 64 Prodarsan R 64 fallopian tube cancers 64 K ras mutations 64 iniparib 64 Resten NG 64 RhuDex TM 64 systemic RNAi therapeutic 64 unresectable tumors 64 Urocidin 64 diabetic neuropathic pain 64 Pivotal Phase III 64 radiotherapeutic 64 hormone LHRH antagonist 64 sunitinib malate 64 glucokinase activator 64 IMiD 64 pegylated liposomal doxorubicin 64 cetuximab Erbitux ® 64 Curaxin 64 Onalta 64 TNF Tumor Necrosis Factor 64 PGL# 64 tafamidis 64 SNT-MC#/idebenone 64 adalimumab Humira 64 relapsed leukemia 64 acute GvHD 64 Pyridorin 64 systemic fungal infections 64 telaprevir dosed 64 abiraterone acetate 64 recurrent glioblastoma multiforme 64 PITX2 methylation 64 immatics 64 pegylated interferons 64 investigational hepatitis C 64 IMC #B 64 baminercept 64 BrachySil ™ 64 cathepsin K inhibitor 64 pseudobulbar affect PBA 64 autologous cellular immunotherapy 64 Capesaris 64 Kepivance 64 ReN# 64 aleglitazar 64 Pemetrexed 64 nucleoside analog 64 IMiDs ® compound 64 RhuDex 64 REG1 Anticoagulation System 64 Menerba 64 trabectedin 64 Neuvenge 64 imetelstat 64 ZFP Therapeutic 64 Lpathomab 64 SYN# 64 HIF PH inhibitors 64 Epanova 64 RSD# 64 farletuzumab 64 Civacir 64 LE DT 64 ART# 64 nitazoxanide 64 TORISEL 64 PLX cells 64 opioid induced bowel dysfunction 64 Surgical resection 64 cetuximab Erbitux R 64 Elocalcitol 63 interleukin IL -# 63 Marqibo 63 5 HT3 antagonist 63 PLK1 SNALP 63 IMiDs ® 63 Cimzia ® certolizumab pegol 63 Reolysin 63 interferon ribavirin 63 diarrhea predominant irritable 63 Gastrointestinal Stromal Tumors 63 Genz # 63 eprotirome 63 Trabectedin 63 ICA # 63 cancer neuroendocrine tumor 63 Cimzia TM 63 STRIDE PD 63 Afatinib 63 Triapine 63 lorvotuzumab mertansine 63 EXPAREL ™ 63 Tesmilifene 63 ADP receptor antagonist 63 Tanespimycin 63 somatostatin analog 63 Aurora kinase 63 epothilone 63 ALN HPN 63 sitaxsentan 63 Indaflex TM 63 GMX# 63 Phase 2a Clinical Trial 63 relapsed ovarian cancer 63 ALN VSP 63 brentuximab vedotin SGN 63 Reverset 63 chemoradiotherapy 63 ChronVac C ® 63 TEMODAL 63 allosteric modulator NAM 63 Tumour Vascular Disrupting Agent 63 Gefitinib 63 cisplatin gemcitabine 63 oral deforolimus 63 dirucotide 63 ancrod 63 Interferon alfa 63 Zerenex 63 BCG refractory carcinoma 63 CORT # 63 orally inhaled migraine 63 MT# MEDI 63 Neuradiab 63 neratinib 63 TRC# 63 PTH analogue 63 sulodexide 63 Bortezomib 63 sapropterin dihydrochloride 63 histone deacetylase inhibitor 63 luteinizing hormone releasing 63 Xelox 63 brivaracetam 63 rhThrombin 63 dermaPACE TM 63 Cetuximab Erbitux 63 polymerase inhibitors 63 Interferon Beta 63 mTOR mammalian target 63 PEGylated interferon beta 1a 63 candidate ridaforolimus 63 ADVEXIN therapy 63 lexidronam injection 63 ToGA 63 CDP# 63 octreotide acetate 63 AzaSite Plus 63 pradefovir 63 PKC# 63 ISTODAX 63 clodronate 63 humanized anti 63 humanized monoclonal antibody 63 exon skipping 63 TYZEKA 63 selective agonist 63 Excellarate 63 Dual Opioid 63 novel nucleoside analog 63 Janus Kinase 63 Onalta ™ 63 small molecule thrombopoietin 63 vandetanib 63 IAP inhibitors 63 MAP# 63 PS# DARA 63 pemetrexed Alimta 63 RIGScan CR 63 Myelofibrosis 63 cartilage regeneration 63 FluCide 63 rhIL 7 63 IMPDH inhibitor 63 human IgG1 monoclonal 63 decitabine 63 ZEVALIN ® 63 antiangiogenic therapy 63 P#X# antagonist 63 EOquin 63 ThGRF 63 gastric adenocarcinoma 63 Diamyd ® 63 predictive biomarkers 63 MGCD# [001] 63 R sorafenib tablets 63 BENLYSTA ™ 63 CDK inhibitor 63 AeroLEF TM 63 TNFa 63 fosbretabulin 63 oral anticancer 63 Fibrillex 63 Lubiprostone 63 radezolid 63 nanopharmaceutical 63 Pradefovir 63 MVA BN R 63 Omigard 63 TEMSO 63 AzaSite TM 63 polymerase inhibitor 63 Cloretazine VNP#M 63 product Fentanyl TAIFUN 63 MYDICAR 63 ARRY # 63 recurrent herpes labialis 63 amrubicin 63 Ceflatonin R 63 Dendreon investigational 63 selective inhibition 63 KRAS mutation 63 uric acid lowering 63 Phase 2b clinical trials 63 Bosutinib 63 oral nucleoside analogue 63 antiangiogenic agent 63 Randomized Double blind 63 cetuximab Erbitux 63 antisense drug